Back to Search
NANCY KEMENY, MD
MD
Medical Oncology Physician
NPI: 1801867841Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
114483(NY)
Research & Publications (20)
Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer.
PMID 19233901·Ann Oncol·2009
3-trial
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma.
PMID 19470932·J Clin Oncol·2009
8-other
Presurgical chemotherapy in patients being considered for liver resection.
PMID 17673614·Oncologist·2007
6-review
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver.
PMID 17107303·Hum Gene Ther·2006
3-trial
Management of liver metastases from colorectal cancer.
PMID 17024869·Oncology (Williston Park)·2006
6-review
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).
PMID 16505413·J Clin Oncol·2006
4-observational
Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
PMID 16028279·J Surg Oncol·2005
3-trial
Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
PMID 16009951·J Clin Oncol·2005
3-trial
Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
PMID 15570076·J Clin Oncol·2004
3-trial
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer.
PMID 12947066·J Clin Oncol·2003
3-trial
Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.
PMID 12559192·J Gastrointest Surg·2003
8-other
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer.
PMID 12196376·Ann Oncol·2002
3-trial
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.
PMID 11352961·J Clin Oncol·2001
3-trial
Hepatic arterial therapy for the treatment of metastatic colorectal cancer.
PMID 11049044·Semin Oncol·2000
6-review
Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience.
PMID 19468688·Invest New Drugs·2010
8-other
Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.
PMID 19491285·Ann Oncol·2009
3-trial
Colorectal hepatic metastases: adjuvant chemotherapy and survival.
PMID 19506154·J Clin Oncol·2009
8-other
Elevated carcinoembryonic antigen and sarcoidosis masquerading as metastatic colon cancer.
PMID 19632934·Clin Colorectal Cancer·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1801867841
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile